10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！ 名额有限，手慢无。让我们共赴可持续之约！【点击报名】 国家药品监督管理局药品审评中心数据显示，2026年10月14日，Amgen Inc.的地舒单抗注射液申请已获受理，受理号为JYSB2600285。
Investor's Business Daily on MSN
At Amgen, sustainability is a companywide commitment
Amgen integrates sustainability goals in every part of its business with a holistic and innovative approach to manufacturing.
Zacks Investment Research on MSN
Here's Why Amgen (AMGN) Fell More Than Broader Market
Amgen (AMGN) closed at $439.26 in the latest trading session, marking a -1.79% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.52%. Meanwhile, the Dow ...
THOUSAND OAKS, Calif., and TOKYO, March 8, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 ...
Amgen's long-standing commitment to U.S. innovation and state-of-the-art operations is reflected in more than $40 billion invested in manufacturing and research and development since the passage of ...
Am 20.10.2026 veröffentlichten Amgen und AstraZeneca vollständige Ergebnisse der Phase-3-Studie CROSSING zu Tezspire. Bei der ...
When a drugmaker's top product loses patent protection, the dividend usually takes the hit. Four pharma giants are each ...
Amgen stock (ISIN US0311621009) was at EUR 396.08 at Lang & Schwarz on October 23, 2026 at 11:17 a.m. CEST. The latest ...
Amgen said it has started two critical late-stage trials for its experimental weight loss injection, MariTide, another step in its bid to enter the booming obesity drug market. MariTide is a monthly ...
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion. Each Horizon shareholder ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果